Covered recipient · General Payments record
NIRAJ M MEHTA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$888.88
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $376.38 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $166.90 | 7 |
| REVANCE THERAPEUTICS, INC. | $104.48 | 3 |
| Exact Sciences Corporation | $31.11 | 2 |
| Astellas Pharma US Inc | $23.14 | 1 |
| ABBVIE INC. | $18.82 | 1 |
| Lilly USA, LLC | $16.77 | 1 |
| Corcept Therapeutics | $15.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.82 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105016582 | CMS |
| Astellas Pharma US Inc | $23.14 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139277464 | CMS |
| Corcept Therapeutics | $15.16 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117775696 | CMS |
| Dexcom, Inc. | $16.38 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153325965 | CMS |
| Dexcom, Inc. | $4.55 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153325967 | CMS |
| Dexcom, Inc. | $5.83 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153325969 | CMS |
| Dexcom, Inc. | $8.17 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153325971 | CMS |
| Dexcom, Inc. | $3.25 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153325973 | CMS |
| Dexcom, Inc. | $121.84 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153325977 | CMS |
| Dexcom, Inc. | $6.88 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153325975 | CMS |
| Exact Sciences Corporation | $17.62 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114784525 | CMS |
| Exact Sciences Corporation | $13.49 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114784531 | CMS |
| Lilly USA, LLC | $16.77 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135249067 | CMS |
| REVANCE THERAPEUTICS, INC. | $16.78 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147924354 | CMS |
| REVANCE THERAPEUTICS, INC. | $40.00 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147924356 | CMS |
| REVANCE THERAPEUTICS, INC. | $47.70 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147924358 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.